Evaluation of the stability of Polymyxin B in saline and glucose solutions using LC-MS/MS

Detalhes bibliográficos
Autor(a) principal: Castilhos, Juliana Kich
Data de Publicação: 2020
Outros Autores: Dillenburg, Thaís Luise, Antunes, Marina Venzon, Scribel, Letícia, Zavascki, Alexandre Prehn, Linden, Rafael, Verza, Simone Gasparin
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Pharmaceutical Sciences
Texto Completo: https://www.revistas.usp.br/bjps/article/view/181520
Resumo: Polymyxins are a group of antibacterial substances and have remained the drugs of choice for treatment of resistant Gram-negative bacilli. Polymyxin B is administered by intravenous infusion and requires the reconstitution of lyophilized powder with 0.9% saline or 5% glucose solutions. To date, there is little information about polymyxin stability in different infusions solutions, especially at 40 ºC, a temperature that is recommended to study drug stability as it accelerates degradation reactions. Therefore, in this work an analytical method using LC-MS/MS was developed, validated and applied to determine the stability of polymyxin B diluted in 0.9% saline or 5% glucose solutions at 25 ºC and 40 ºC. The stability of polymyxin B solutions was evaluated during 72 hours. Polymyxin B1 and B2 were stable for 24 hours in saline (0.9%) and glucose solution (5%), however a significant degradation of polymyxin B1 and B2 was observed after 48 hours and 72 hours of assay. The reduction of polymyxin content was evidenced in both saline and glucose media, at room temperature as well as at 40 °C. No significant differences in pH of polymyxin solutions (glucose or saline) were evidenced during stability assay.
id USP-31_253150d38bf0bb58030afcdcad3cbf58
oai_identifier_str oai:revistas.usp.br:article/181520
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
repository_id_str
spelling Evaluation of the stability of Polymyxin B in saline and glucose solutions using LC-MS/MSPolymyxinStabilityLC-MS/MSGlucose solutionsSaline solutionsPolymyxins are a group of antibacterial substances and have remained the drugs of choice for treatment of resistant Gram-negative bacilli. Polymyxin B is administered by intravenous infusion and requires the reconstitution of lyophilized powder with 0.9% saline or 5% glucose solutions. To date, there is little information about polymyxin stability in different infusions solutions, especially at 40 ºC, a temperature that is recommended to study drug stability as it accelerates degradation reactions. Therefore, in this work an analytical method using LC-MS/MS was developed, validated and applied to determine the stability of polymyxin B diluted in 0.9% saline or 5% glucose solutions at 25 ºC and 40 ºC. The stability of polymyxin B solutions was evaluated during 72 hours. Polymyxin B1 and B2 were stable for 24 hours in saline (0.9%) and glucose solution (5%), however a significant degradation of polymyxin B1 and B2 was observed after 48 hours and 72 hours of assay. The reduction of polymyxin content was evidenced in both saline and glucose media, at room temperature as well as at 40 °C. No significant differences in pH of polymyxin solutions (glucose or saline) were evidenced during stability assay.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2020-12-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/18152010.1590/s2175-97902019000318367Brazilian Journal of Pharmaceutical Sciences; Vol. 56 (2020); e18367Brazilian Journal of Pharmaceutical Sciences; v. 56 (2020); e18367Brazilian Journal of Pharmaceutical Sciences; Vol. 56 (2020); e183672175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/181520/168538Copyright (c) 2020 Brazilian Journal of Pharmaceutical Scienceshttp://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessCastilhos, Juliana Kich Dillenburg, Thaís Luise Antunes, Marina Venzon Scribel, Letícia Zavascki, Alexandre Prehn Linden, Rafael Verza, Simone Gasparin 2021-06-12T19:46:54Zoai:revistas.usp.br:article/181520Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2021-06-12T19:46:54Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Evaluation of the stability of Polymyxin B in saline and glucose solutions using LC-MS/MS
title Evaluation of the stability of Polymyxin B in saline and glucose solutions using LC-MS/MS
spellingShingle Evaluation of the stability of Polymyxin B in saline and glucose solutions using LC-MS/MS
Castilhos, Juliana Kich
Polymyxin
Stability
LC-MS/MS
Glucose solutions
Saline solutions
title_short Evaluation of the stability of Polymyxin B in saline and glucose solutions using LC-MS/MS
title_full Evaluation of the stability of Polymyxin B in saline and glucose solutions using LC-MS/MS
title_fullStr Evaluation of the stability of Polymyxin B in saline and glucose solutions using LC-MS/MS
title_full_unstemmed Evaluation of the stability of Polymyxin B in saline and glucose solutions using LC-MS/MS
title_sort Evaluation of the stability of Polymyxin B in saline and glucose solutions using LC-MS/MS
author Castilhos, Juliana Kich
author_facet Castilhos, Juliana Kich
Dillenburg, Thaís Luise
Antunes, Marina Venzon
Scribel, Letícia
Zavascki, Alexandre Prehn
Linden, Rafael
Verza, Simone Gasparin
author_role author
author2 Dillenburg, Thaís Luise
Antunes, Marina Venzon
Scribel, Letícia
Zavascki, Alexandre Prehn
Linden, Rafael
Verza, Simone Gasparin
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Castilhos, Juliana Kich
Dillenburg, Thaís Luise
Antunes, Marina Venzon
Scribel, Letícia
Zavascki, Alexandre Prehn
Linden, Rafael
Verza, Simone Gasparin
dc.subject.por.fl_str_mv Polymyxin
Stability
LC-MS/MS
Glucose solutions
Saline solutions
topic Polymyxin
Stability
LC-MS/MS
Glucose solutions
Saline solutions
description Polymyxins are a group of antibacterial substances and have remained the drugs of choice for treatment of resistant Gram-negative bacilli. Polymyxin B is administered by intravenous infusion and requires the reconstitution of lyophilized powder with 0.9% saline or 5% glucose solutions. To date, there is little information about polymyxin stability in different infusions solutions, especially at 40 ºC, a temperature that is recommended to study drug stability as it accelerates degradation reactions. Therefore, in this work an analytical method using LC-MS/MS was developed, validated and applied to determine the stability of polymyxin B diluted in 0.9% saline or 5% glucose solutions at 25 ºC and 40 ºC. The stability of polymyxin B solutions was evaluated during 72 hours. Polymyxin B1 and B2 were stable for 24 hours in saline (0.9%) and glucose solution (5%), however a significant degradation of polymyxin B1 and B2 was observed after 48 hours and 72 hours of assay. The reduction of polymyxin content was evidenced in both saline and glucose media, at room temperature as well as at 40 °C. No significant differences in pH of polymyxin solutions (glucose or saline) were evidenced during stability assay.
publishDate 2020
dc.date.none.fl_str_mv 2020-12-09
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/181520
10.1590/s2175-97902019000318367
url https://www.revistas.usp.br/bjps/article/view/181520
identifier_str_mv 10.1590/s2175-97902019000318367
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/181520/168538
dc.rights.driver.fl_str_mv Copyright (c) 2020 Brazilian Journal of Pharmaceutical Sciences
http://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2020 Brazilian Journal of Pharmaceutical Sciences
http://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 56 (2020); e18367
Brazilian Journal of Pharmaceutical Sciences; v. 56 (2020); e18367
Brazilian Journal of Pharmaceutical Sciences; Vol. 56 (2020); e18367
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1800222915092807680